1. Home >
  2. M&A >
  3. Growth Capital >
  4. Switzerland >
  5. SHS Capital Invests In Simulands

Investment Summary

SHS Capital Invests In Simulands

On March 2, 2023, private equity firm SHS Capital invested in medical products company Simulands

Investment Highlights
  • This is SHS Capital’s 18th transaction in the Medical Products sector.
  • This is SHS Capital’s 7th transaction in Switzerland.

Investment Summary
Date 2023-03-02
Target Simulands
Sector Medical Products
Investor(s) SHS Capital
Deal Type Growth Capital

Target

Simulands

Zurich, Switzerland
Simulands is a medical simulation company focused on developing and commercializing innovative simulation solutions for healthcare training. Simulands leveraging longstanding expertise of medical devices development, and novel manufacturing techniques seeking to revolutionize R&D and Education in the cardiovascular space. Simulators offer solutions that are more practical, cost effective, and ethical versus traditional animal research practices. Simulands was founded in 2019 and is based in Zurich, Switzerland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

SHS Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
Size Small
Type Sector Focused
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.

DEAL STATS #
Overall 32 of 35
Sector: Medical Products M&A 18 of 19
Type: Growth Capital M&A Deals 20 of 21
Country: Switzerland M&A 7 of 7
Year: 2023 M&A 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-28 Blazejewski MEDI-TECH

Sexau, Germany

Blazejewski MEDI-TECH develops, produce and distributes medical endoscopes that are used in operating rooms all over the world. The product range includes rigid and semirigid 2D endoscopes (including with chip on-the-tip technology) that deliver images of very good quality. The firm also manufactures 3D endoscopes that offer excellent spatial representation and, with an outer diameter of less than 2.5 millimeters, are unique worldwide. Blazejewski MEDI-TECH was founded in 1991 and is based in Sexau, Germany.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-22 MESI

Ljubljana, Slovenia

MESI is an innovative company committed to digitalizing healthcare at primary level and beyond. Its core product, the MESI mTABLET, enabled them to introduce a new diagnostic category: predictive medical assessment. This is a combination of digital diagnostic measurements, immediate storage and availability of patient records, clinical support tools, and clinical AI recommendations on one device. MESI was founded in 2010 and is based in Ljubljana, Slovenia.

Buy -
Mergr

Solution for

Product

Company

Legal